Details

Autor(en) / Beteiligte

• Mérida-García, Antonio
• Díaz-Serrano, Asunción
• Bernard, Brandon
• del Mar Galera, María
• de Velasco, Guillermo
• Sepúlveda, Juan Manuel
• Fernández, Lourdes
• Medina, Javier
• Castellano, Daniel

Titel

Update on the management of patients with intermediate and poor-risk testicular germ cell tumors and new biological insights

Ist Teil von

• Cancer treatment and research communications, 2019, Vol.19, p.100117-100117, Article 100117

Ort / Verlag

Elsevier Ltd

Erscheinungsjahr

2019

Quelle

Alma/SFX Local Collection

Beschreibungen/Notizen

• Highlights•BEP remains the first-line standard treatment in patients with germ cell tumors.•TIP or HDCT can provide favorable benefits in poor-risk GCT compared to BEP.•An adaptive treatment may be proposed according to the decrease in serum biomarkers.•Patients will receive personalized treatment based on molecular biology.